Amandine Ségot (Amandine Segot)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Diffuse Large B Cell Lymphoma

Tyrosine Kinase

Cerebrospinal Fluid

Chronic Myeloid Leukemia

Top Venues

American journal of hematology

Revue medicale suisse

This page only lists publications with an associated author ORCID identifier.

Publications

Valentin Loser, Amandine Ségot, Laurence L de Leval, Bettina Bisig, Jean-Philippe Brouland, Ekkehard Hewer, Carmen Barcena, Andreas F Hottinger, Caroline Pot
Primary diffuse large B-cell lymphoma of the central nervous system identified with CSF biomarkers. BMC neurology 24 (1) (2024)
Julien Dereme, Amandine Ségot
Deep blue. Blood 143 (12) (2024)
Julien Dereme, Amandine Ségot
Deep blue. Blood 143 (12) (2024)
Valentin Loser, Amandine Ségot, Laurence L de Leval, Bettina Bisig, Jean-Philippe Brouland, Ekkehard Hewer, Carmen Barcena, Andreas F Hottinger, Caroline Pot
Primary diffuse large B-cell lymphoma of the central nervous system identified with CSF biomarkers. BMC neurology 24 (1) (2024)
Valentin Loser, Amandine Ségot, Laurence L de Leval, Bettina Bisig, Jean-Philippe Brouland, Ekkehard Hewer, Carmen Barcena, Andreas F Hottinger, Caroline Pot
Primary diffuse large B-cell lymphoma of the central nervous system identified with CSF biomarkers. BMC neurology 24 (1) (2024)
Julien Dereme, Amandine Ségot, Noemy Friedrich, Gerasimos Tsilimidos, Sabine Blum
[Recognizing and managing side effects of tyrosine kinase inhibitors in chronic myeloid leukemia]. Revue medicale suisse 19 (850) (2023)
Amandine Ségot, Marcel Adler, Alessandro Aliotta, Elena Matthey-Guirao, Michael Nagler, Debora Bertaggia Calderara, Francesco Grandoni, Francisco Javier Gomez, Lorenzo Alberio
Low COAT platelets are frequent in patients with bleeding disorders of unknown cause (BDUC) and can be enhanced by DDAVP. Journal of thrombosis and haemostasis : JTH 20 (5) (2022)
Amandine Ségot, Grégoire Stalder, Laurence de Leval, Françoise Solly, Jacqueline Schoumans, Valentin Basset, Sabine Blum, Olivier Spertini
Venetoclax combined with FLAG-based chemotherapy induces an early and deep response in mixed-phenotype-acute leukemia. American journal of hematology 97 (3) (2021)